Tricuspid Valve Insufficiency

Tricuspid Valve Insufficiency, also known as tricuspid regurgitation, is related to cardiogenic shock and right bundle branch block. An important gene associated with Tricuspid Valve Insufficiency is PTPN11 (Protein Tyrosine Phosphatase Non-Receptor Type 11), and among its related pathways/superpathways are Signal Transduction and Development_Leptin signaling via JAK/STAT and MAPK cascades. The drugs Tolvaptan and Torasemide have been mentioned in the context of this disorder. Affiliated tissues include heart and liver, and related phenotypes are muscle and normal